A OHD COST Action & GP2A & PaulEhrlich joint event 11-13 June 2025 - DEADLINE POSPONED 11 APRIL

Dear Colleagues, Dear Researchers,

The GP2A (Group for the Promotion of Pharmaceutical chemistry in Academia), the Paul Ehrlich MedChem Euro-PhD Network and the COST Action OneHealthdrugs  are delighted to announce the joint event 33rd Annual GP2A Medicinal Chemistry Conference, XIVth Paul Ehrlich MedChem Euro-PhD Network Meeting & COST Action One Health drugs against parasitic vector borne diseases in Europe and beyond at Nantes Université, France, 11-13th June 2025.

The COST Action meeting will be held at the Amphitheatre Virginie Ferré, School of Pharmacy – 9 rue Bias 44035 Nantes (GPS 47.2101322, -1.5574098). This is a co-funded initiative in which the OHD COST Action participates with a dedicated session on Thursday, June 12, 2025, from 9:00 AM to 12:20 PM, at the Amphitheatre Virginie Ferré, School of Pharmacy NU.

Medicinal chemistry programs will be presented by PhD candidates within the context of the annual meeting of the European group GP2A and Paul Ehrlich medchem event 2025. This event presents a unique opportunity to promote antiparasitic drug research initiatives among young researchers and innovators. This field requires a critical mass to achieve broader representation and greater impact, particularly by emphasizing the concept of the environmental impact of drugs.

REGISTRATION AVAILABLE AT THE MEETING WEBSITE: https://gp2a.org/index.php/gp2a-2025-paul-ehrlich-medchem-2025-nantes-france-june-11th-to-13th-2025/

 

OTHER INFORMATION

The abstract template (oral & poster) and information for submission are available here!  You can submit your abstract, using the dedicated Word template, and send it as a DOCX file to gp2a-pe2025@gp2a.org by the 29th of March 2025 - POSPONED TO 11 April.

Abstract submission and poster/communication will eventually not be considered if the main author is not fully registered as a participant to the conference by the closing date for abstract submission (29th March).

Application for oral communication: The organising committee will select more than 14 attendees, from the submitted abstracts, to be upgraded to oral communications. Please select “no communication” in case you do not wish to be considered for an oral communication, to notify the organising committee of your preference.

The date for final registration (without abstract submission) is 16th May.

Any further enquiries can be directed to: gp2a-pe2025@gp2a.org

Book of abstract PHD COST Action Annual conference 2025

QUICK RULES FOR IN PRESENCE MEETING REIMBURSEMENT 2025

Programme of the meeting

Report of the meeting - Publication in Drug Discovery

Abstract

The 33rd Annual Conference of the Group for the Promotion of Pharmaceutical Chemistry in Academia (GP2A), held in Nantes from 11 to 13 June 2025, marked a significant expansion of the organization’s scope and collaborative efforts. Building on the success of the previous meeting in Coimbra, the 2025 edition brought together 168 participants and featured a comprehensive scientific programme comprising 102 abstracts. A key highlight of this year’s conference was the collaboration with COST Action OneHealthdrugs and the Paul Ehrlich (PE) Euro-PhD Network, fostering interdisciplinary exchange and identifying future research synergies. The event included 1 computational workshop and 8 keynote lectures by international experts, alongside a strong emphasis on early-career researchers, with 25 oral presentations and 25 flash poster communications. In addition, 77 posters were presented across three dedicated sessions. All the presentations were eligible for 18 conference awards. Staying true to the GP2A and PE mission, the conference provided a dynamic platform for young scientists to engage with established researchers.

Minute - 33rd GP2A Annual Medicinal Chemistry Conference, XIVth Paul Ehrlich MedChem Euro-PhD Network Meeting & COST Action One Health Drugs Against Parasitic Vector Borne Diseases in Europe and Beyond (OneHealthdrugs)

COST
What is COST?

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. The COST ACTIONS help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

OneHealthdrugs CA21111
Title:

One Health drugs against parasitic vector borne diseases in Europe and beyond

Acronym:

OneHealthdrugs

Start date of the Action:

24/10/2022

End date of the Action:

23/10/2026

CSO approval date:

27/05/2022

Memorandum of Understanding (MoU)

Download file

Contact Points
Chair:

Maria Paola Costi

Vice-Chair:

Anabela Cordeiro da Silva

COST staff

Scientific Officer:
Wioleta Walentowska
Administrative Officer:
Nathalie Warenghien

Administrative Team

Maria Cristina Notarsanto
Maria Esposito and Laura Leonardi